Benefits
T2D insulin sensitivity 12-week tea RCT (NCT01254084 PMC3572697)
NCT01254084 PMC3572697 — Hanoi Medical University + Karolinska Institutet phase 1/2 RCT in 24 drug-naïve T2D patients. 6 g/day GP tea (3 g BID, 30 min before breakfast + dinner) × 10-12 weeks vs placebo. RESULTS: REDUCTION in plasma glucose + DECREASE in HbA1c by 2%. Foundational diabetes evidence — drug-naïve T2D crossover design.
Sulfonylurea add-on T2D RCT (NCT00808860 PMC3484409)
NCT00808860 PMC3484409 — Hanoi Medical University + Karolinska 4-week run-in + RCT. Drug-naïve newly-diagnosed T2D + Gliclazide MR 30 mg/day + GP tea 3 g BID vs placebo tea. Add-on therapy with SULFONYLUREAS. Foundational T2D combination therapy evidence — supports clinically practical use case.
Exercise performance + AMPK 4-week crossover (PMC10675532)
PMC10675532 — randomized double-blind placebo-controlled CROSSOVER in 16 healthy untrained young males. 450 mg G. pentaphyllum dried leaf extract (= 2.25 g dry leaf) × 4 weeks vs placebo. RESULTS: significantly LOWER leptin + blood glucose; IMPROVED 20-km time trial performance; HIGHER muscle oxygen flux; INCREASED muscle AMPK Thr172 phosphorylation post-60-min exercise.
ActivAMP body composition 12-week RCT (Rao 2022)
Rao 2022 (J Hum Nutr Diet, doi:10.1111/jhn.12936) — double-blind randomized placebo-controlled study of orally-dosed ActivAMP® (G. pentaphyllum) on body composition in OVERWEIGHT adults. 80 obese subjects (BMI ≥25, WHR ≥0.90 male / ≥0.85 female), 450 mg/day for 12 weeks. RESULTS: total abdominal fat area, body weight, body fat mass, %body fat, BMI all SIGNIFICANTLY DECREASED.
Anxiety reduction chronic stress RCT (ScienceDirect)
Choi 2019 — randomized double-blind placebo-controlled clinical trial. G. pentaphyllum LEAF EXTRACT supplementation in healthy subjects with CHRONIC PSYCHOLOGICAL STRESS. RESULTS: REDUCED anxiety. Foundational adaptogen mechanism — adds anxiolytic dimension to metabolic + exercise benefits. Distinguishing multi-system positioning.
AMPK activation mechanism (foundational)
AMP-activated protein kinase (AMPK) ACTIVATION is a key mechanism for G. pentaphyllum glycolipid metabolism regulation. PPAR/UCP-1/PGC-1α/PRDM16 + (SREBP-1c)-ACC/FAS-CPT1 triglyceride pathways; (SREBP-2)-HMGCR + PCSK9-LDLR + bile acid biosynthetic cholesterol pathways. >328 saponins identified — gypenosides + actiponin.
HONEST mild side effects + safety
HONEST framing: generally well-tolerated but may cause NAUSEA + DIARRHEA in some users. >2000 year traditional 'immortality herb' use record — 'Southern ginseng' positioning vs Panax. Cucurbitaceae family (cucumber relative) NOT actually ginseng despite common name. Distinguishing botanical heritage.
Mechanism of action
AMPK Thr172 phosphorylation activation
PMC10675532 — increased muscle AMPK Thr172 phosphorylation post-exercise. Key AMPK activator mechanism — same pathway as metformin + exercise. Foundational metabolic + exercise mechanism.
Hypolipidemic SREBP/HMGCR/PCSK9 pathways
Cholesterol-lowering via (SREBP-2)-HMGCR + PCSK9-LDLR + bile acid biosynthetic pathways. Triglyceride reduction via PPAR/UCP-1/PGC-1α/PRDM16 + (SREBP-1c)-ACC/FAS-CPT1 pathways. Mechanism: multi-target lipid metabolism.
Insulin sensitivity + glucose uptake
NCT01254084 — improved insulin sensitivity in T2D patients (HbA1c 2% reduction). Mechanism: AMPK-mediated GLUT4 translocation + insulin signaling enhancement.
Mitochondrial respiration + oxygen flux
PMC10675532 — higher muscle oxygen flux. Mechanism: mitochondrial respiration enhancement supporting endurance performance + cardiometabolic health.
Leptin reduction + adipose modulation
Lower leptin levels + abdominal fat reduction (Rao 2022 ActivAMP). Mechanism: metabolic hormone modulation + adipose tissue reduction supporting weight management.
Anxiolytic via HPA axis
Choi 2019 chronic stress RCT — anxiety reduction. Mechanism: HPA axis modulation + GABAergic effects supporting traditional 'immortality herb' adaptogen positioning.
Clinical trials
Randomized phase 1/2 quadruple-masked crossover trial (Hanoi Medical University + Karolinska Institutet).
24 drug-naïve T2D patients (newly diagnosed per WHO criteria, ages 40-70, antidiabetic-drug-naïve, FPG 7-11 mmol/L, HbA1c 7-9%). 6 g/day GP tea (3 g packets BID, 30 min before breakfast + dinner) × 10-12 weeks vs placebo tea. Status: COMPLETED.
REDUCTION in plasma glucose + DECREASE in HbA1c by 2%. Foundational pivotal diabetes evidence — drug-naïve T2D population, rigorous quadruple-masked crossover design. International collaboration (Vietnam-Sweden) supports research credibility.
Randomized double-blind placebo-controlled crossover trial.
16 healthy untrained young males. 450 mg G. pentaphyllum dried leaf extract (= 2.25 g dry leaf) × 4 weeks vs placebo, separated by 4-week wash-out. 20-km time trial + Cosmed Quark CPET breath-by-breath gas analysis + muscle biopsy AMPK + ACC-α phosphorylation analysis.
Significantly LOWER leptin + blood glucose. IMPROVED 20-km time trial performance. HIGHER muscle oxygen flux. INCREASED muscle AMPK Thr172 phosphorylation post-60-min exercise. Total ACC-α LOWER. Foundational exercise performance + AMPK mechanism evidence in healthy population.
Double-blind randomized placebo-controlled study (Rao 2022, J Hum Nutr Diet, doi:10.1111/jhn.12936).
80 obese subjects (40 ActivAMP® group + 40 placebo). Inclusion: BMI ≥25 kg/m², WHR ≥0.90 male / ≥0.85 female, no diagnosed disease. 450 mg/day ActivAMP® heat-processed extract × 12 weeks.
Significant DECREASES in: total abdominal fat area (P=0.044), body weight (P<0.05), body fat mass (P<0.0001), percent body fat (P<0.0001), BMI. Foundational body composition evidence supporting heat-processed actiponin extract for weight management. ActivAMP® branded research base.
About this ingredient
GYNOSTEMMA PENTAPHYLLUM (Thunb.) Makino is JIAOGULAN ('immortality herb') — CUCURBITACEAE FAMILY (cucumber relative, NOT Araliaceae like true ginsengs). Despite common name 'SOUTHERN GINSENG,' it is botanically NOT actual ginseng. Used in China for diabetes, hyperlipidemia, cardiovascular disease, fatty liver disease, obesity. First recorded in 'Herbal for Relief of Famines' + Compendium of Materia Medica. Active compounds: GYPENOSIDES (>328 saponins identified — structurally similar to ginsenosides), FLAVONOIDS, ACTIPONIN (heat-processed extract), DAMULIN A/B. PIVOTAL CLINICAL EVIDENCE: NCT01254084 PMC3572697 — Hanoi Medical University + Karolinska Institutet phase 1/2 RCT in 24 drug-naïve T2D patients. 6 g/day GP tea (3 g BID, 30 min before breakfast + dinner) × 10-12 weeks. RESULTS: reduction in plasma glucose + 2% HbA1c decrease. NCT00808860 PMC3484409 — sulfonylurea (Gliclazide MR 30 mg) add-on therapy RCT. PMC10675532 — 16-pt 4-week crossover with 450 mg dried leaf extract (= 2.25 g dry leaf): lower leptin + blood glucose, improved 20-km time trial, higher muscle oxygen flux, INCREASED muscle AMPK Thr172 phosphorylation post-exercise. RAO 2022 (J Hum Nutr Diet, doi:10.1111/jhn.12936) — ActivAMP® 80-pt 12-week obesity RCT: total abdominal fat + body weight + body fat mass + %body fat + BMI all SIGNIFICANTLY DECREASED. CHOI 2019 — chronic stress anxiety reduction RCT. AMPK ACTIVATION is THE KEY mechanism — same pathway as metformin + exercise.
MECHANISMS: AMPK Thr172 PHOSPHORYLATION activation (PMC10675532); HYPOLIPIDEMIC SREBP/HMGCR/PCSK9 pathways (cholesterol) + PPAR/UCP-1/PGC-1α/PRDM16 + (SREBP-1c)-ACC/FAS-CPT1 (triglycerides); INSULIN SENSITIVITY + glucose uptake (NCT01254084 HbA1c 2% reduction); MITOCHONDRIAL RESPIRATION + oxygen flux (PMC10675532); LEPTIN REDUCTION + adipose modulation (Rao 2022); ANXIOLYTIC via HPA axis (Choi 2019). EVIDENCE: 4/5 reflects: (1) NCT01254084 PMC3572697 PIVOTAL Hanoi-Karolinska T2D RCT (HbA1c 2% reduction), (2) NCT00808860 sulfonylurea add-on RCT (combination therapy practical), (3) PMC10675532 exercise + AMPK crossover RCT (mechanism + performance), (4) RAO 2022 ActivAMP 80-pt body composition RCT (significant fat/weight reductions), (5) CHOI 2019 chronic stress anxiety RCT (multi-system adaptogen), (6) AMPK activation foundational mechanism (>328 saponins identified, same target as metformin + exercise), (7) MULTI-INDICATION evidence base (T2D, exercise performance, body composition, anxiety, lipids), (8) HEAT-PROCESSED ACTIPONIN/ActivAMP® branded research base, (9) HONEST FRAMING — Cucurbitaceae NOT Araliaceae (not actually ginseng despite common name), nausea/diarrhea possible side effects, (10) higher-evidence than typical 'immortality herb' supplement due to multi-RCT + dedicated AMPK mechanism research. SAFETY: Excellent — 12-week multi-RCT record + extensive Asian use. Best positioned as: (a) T2D INSULIN SENSITIVITY + GLYCEMIC CONTROL adjunct (NCT01254084 evidence), (b) METFORMIN-LIKE AMPK ACTIVATOR (PMC10675532 mechanism), (c) EXERCISE PERFORMANCE + ENDURANCE support (PMC10675532 20-km time trial), (d) BODY COMPOSITION + WEIGHT MANAGEMENT (Rao 2022 ActivAMP RCT), (e) CHRONIC STRESS + ANXIETY adaptogen (Choi 2019), (f) CARDIOMETABOLIC adjunct (lipid + glucose multi-target), (g) SULFONYLUREA COMBINATION studied (NCT00808860), (h) DIABETES MEDICATIONS: theoretical hypoglycemia — monitor, (i) PREGNANCY: limited data, (j) higher-evidence than typical adaptogen due to multi-RCT methodology + AMPK mechanism. Honest framing: Gynostemma pentaphyllum (Jiaogulan / 'Southern ginseng') has STRONG EMERGING EVIDENCE base — Hanoi-Karolinska NCT01254084 T2D HbA1c 2% reduction + PMC10675532 exercise/AMPK crossover + Rao 2022 ActivAMP body composition trifecta supports multi-system applications. AMPK ACTIVATION is biochemically distinguishing — same target as metformin + exercise.
CRITICAL HONEST NOTE: NOT actually ginseng despite 'Southern ginseng' name — Cucurbitaceae family (cucumber relative) vs Araliaceae (Panax). Heat-processed actiponin/ActivAMP® branded research base supports trial-matched formulation. Mild GI side effects (nausea/diarrhea) possible. Reasonable cardiometabolic + exercise + body composition adaptogen based on multi-RCT evidence — particularly compelling for those wanting AMPK activation alternative or Western-validated adaptogen with metabolic + performance applications. Strong evidence-to-affordability ratio among adaptogens.